Nfasc Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NFASC (Neurofascin) is a neuronal cell adhesion molecule belonging to the L1 family of immunoglobulin superfamily proteins. NFASC plays critical roles in nervous system development and function, including axon guidance, synapse formation, and node of Ranvier assembly. The protein exists in multiple isoforms with distinct functions: NFASC186 (also called neurofascin-186) is primarily neuronal, while NFASC155 is expressed in glial cells. Mutations in NFASC have been associated with neurological disorders including hereditary spastic paraplegia and multiple sclerosis.
NFASC is a type I transmembrane glycoprotein with an extracellular domain containing immunoglobulin-like domains and fibronectin type III repeats. The protein mediates homophilic and heterophilic interactions with other cell adhesion molecules.
During nervous system development, NFASC mediates axon guidance through:
NFASC186 is essential for the assembly and maintenance of nodes of Ranvier:
The axon initial segment is the site where action potentials are initiated. NFASC186:
NFASC participates in synaptogenesis:
NFASC mutations cause a recessive form of hereditary spastic paraplegia (SPG60). The disease is characterized by:
NFASC has been implicated in multiple sclerosis:
NFASC mutations have been linked to Charcot-Marie-Tooth disease, a peripheral neuropathy:
Node of Ranvier Dysfunction: NFASC mutations disrupt node integrity, leading to:
Axon Initial Segment Abnormalities: Defective AIS function affects:
Myelin Sheath Defects: Glial NFASC155 dysfunction may impair:
NFASC may play roles in AD through:
NFASC represents a potential therapeutic target:
Node Stabilization: Enhancing NFASC function could stabilize nodes of Ranvier in demyelinating diseases.
Axon Regeneration: NFASC-based strategies could promote axon regeneration after injury.
Immunomodulation: Targeting NFASC autoimmunity may benefit MS patients.
NFASC mutations can be identified through:
NFASC interacts with several key proteins:
The study of Nfasc Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Davis JQ, et al. Ankyrin-binding proteins NF186 and NF155. J Cell Biol. 1996
Zonta B, et al. Glial neurofascin155 assembles perineuronal nets. J Neurosci. 2008
Almeida RG, et al. Neurofascin and myelin. Nat Rev Neurosci. 2011
Martens LH, et al. Neurofascin mutations cause hereditary spastic paraplegia. Am J Hum Genet. 2012
Coman I, et al. Neurofascin in autoimmune demyelination. J Clin Invest. 2016